loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 2431300 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    SANIS HEALTH INC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 EZETIMIBE (1)

    filter

    01 SANIS HEALTH INC (1)

    filter

    01 TABLET (1)

    filter

    01 10MG (1)

    filter

    01 Canada (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Canada
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Ezetimibe

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET
      10MG
      EZETIMIBE
      Canada
      2431300
      Prescription
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 2431300

      Looking for CTD TGA MCC DOSSIER APPLICATION 2431300 1

      19

      SANIS HEALTH INC, based in Canada, is a pharmaceutical company.

      One of their notable products is EZETIMIBE, with a corresponding application number 2431300 and regulatory information .

      proudly manufactured in the

      SANIS HEALTH INC's EZETIMIBE TABLET, medication with 10MG of EZETIMIBE.

      Post Enquiry
      POST ENQUIRY